ACTAVIS MID ATLANTIC FDA Approval ANDA 205654

ANDA 205654

ACTAVIS MID ATLANTIC

FDA Drug Application

Application #205654

Application Sponsors

ANDA 205654ACTAVIS MID ATLANTIC

Marketing Status

Prescription001

Application Products

001SUPPOSITORY;RECTAL1GM0MESALAMINEMESALAMINE

FDA Submissions

UNKNOWN; ORIG1AP2020-08-14STANDARD

Submissions Property Types

ORIG1Null29

TE Codes

001PrescriptionAB

CDER Filings

ACTAVIS MID ATLANTIC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 205654
            [companyName] => ACTAVIS MID ATLANTIC
            [docInserts] => ["",""]
            [products] => [{"drugName":"MESALAMINE","activeIngredients":"MESALAMINE","strength":"1GM","dosageForm":"SUPPOSITORY;RECTAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/14\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-08-14
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.